Soligenix, Inc. Registration Statement Declared Effective
Ticker: SNGX · Form: EFFECT · Filed: 2026-04-03T00:15:15-04:00
Sentiment: neutral
Topics: registration-statement, effectiveness, sec-filing
TL;DR
SOLIGENIX EFFECTIVE 4/2/26 - SEC OK'd registration statement.
AI Summary
Soligenix, Inc. filed an EFFECT form with the SEC on April 3, 2026, indicating the effectiveness of a registration statement. The effectiveness date is April 2, 2026, related to Act 33 and File No. 333-290413.
Why It Matters
This filing signifies that Soligenix, Inc. has met the SEC's requirements for its registration statement, potentially paving the way for new securities offerings or other corporate actions.
Risk Assessment
Risk Level: medium — Effectiveness of a registration statement is a procedural step, and the actual risk depends on the underlying securities and the company's financial health.
Key Numbers
- 2026-04-02 — Effectiveness Date (The date the SEC declared the registration statement effective.)
- 2026-04-03 — Filing Date (The date the filing was accepted by the SEC.)
Key Players & Entities
- SOLIGENIX, INC. (company) — Filer
- 9999999995-26-001064 (dollar_amount) — SEC Accession Number
- 2026-04-03 (date) — Filing Acceptance Date
- 2026-04-02 (date) — Effectiveness Date
- 333-290413 (dollar_amount) — File Number
FAQ
What type of registration statement has become effective for Soligenix, Inc.?
The filing indicates an 'EFFECT' form, signifying the effectiveness of a registration statement under Act 33.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 9999999995-26-001064.
When did the registration statement officially become effective?
The effectiveness date is April 2, 2026.
What is the CIK number for Soligenix, Inc.?
The CIK number for Soligenix, Inc. is 0000812796.
What is the File Number associated with this registration statement?
The File Number is 333-290413.
From the Filing
EDGAR Filing Documents for 9999999995-26-001064 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001064 Accepted 2026-04-03 00:15:15 Documents 1 Effectiveness Date 2026-04-02 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 598 Complete submission text file 9999999995-26-001064.txt 2028 Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200 SOLIGENIX, INC. (Filer) CIK : 0000812796 (see all company filings) EIN. : 411505029 | State of Incorp.: DE | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-290413 | Film No.: 26836692 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)